Navigation Links
Reproductive Genetics to Enable Higher Success Rates and Prevent Transmission of Genetic Disorders: Igenomix
Date:2/7/2017

DUBAI, UAE, February 7, 2017 /PRNewswire/ --

As a pioneer in reproductive genetics, Igenomix has continuously invested in research and development to bring out new and effective techniques, which today contribute significantly to the assisted reproduction techniques industry.

     (Logo: http://photos.prnewswire.com/prnh/20161214/449323LOGO)

Igenomix is helping most of the clinicians in the Middle East to increase the pregnancy rate by 24% with the use of ERA (Endometrial Receptivity Analysis). This study was presented by Professor Simón, Scientific Director of Igenomix at the 72nd American Society for Reproductive Medicine Scientific Congress (ASRM) and has been awarded as Prize Paper by the Society for Reproductive Endocrinology and Infertility (SREI) in October last year. The ERA test personalizes treatment and works out the day on which the embryo transfer will be successful for 85% of patients.

Igenomix can support the families and clinicians to reduce the risk of having an affected child with a genetic disorder. Carrier Genetic Test (CGT) by Igenomix is another state-of-the-art screening technique that analyse more than 600 diseases to identify the risk of transmission of genetic disorder to the child before conception. 90% of the cases analyzed by Igenomix so far are carriers of at least one mutation which poses a great risk for the child. The risks of genetic disorders are greater for children born to consanguineous couples. In a recent study, 19.7% of the consanguineous couples were at a high risk of passing on the genetic disorder to their child. PGD (Preimplantation Genetic Diagnosis) can be employed in cases where both parents are carriers of the same genetic disorder to help them conceive a healthy baby through IVF.

Chromosomal abnormalities such as Down's syndrome are extremely common, especially in older pregnancies. NACE is a non-invasive prenatal test that screens the baby for common chromosomal abnormalities without any threat to the mother or the child as it maybe in case of invasive techniques such as amniocentesis. The test also reveals the baby's gender and fetal fraction data for ease of diagnosis for gynecologists and other concerned specialists.

With over two decades of experience in reproductive genetics, Igenomix is one of the global leaders with presence in 50 countries. They have also been awarded accreditation by College of American Pathologist (CAP) for its quality standards and are the first private genetic lab in Dubai to receive it.

Further information about the company at http://www.igenomix.ae


Media Contacts:
Divya Bhasin
Email: divya.bhasin@igenomix.com
Phone: +91-9958065684



'/>"/>
SOURCE Igenomix
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Reproductive Medicine Associates of New York Collaborates with EMD Serono to Offer Treatment Assistance to Eligible Veterans and their Spouses
2. Wink by Kindara Lets Women Take Charge of their Reproductive Health & Fertility Goals
3. S-equol Supplements Associated with Improvements in Measures of Reproductive Health in Postmenopausal Women
4. Opioid painkillers widely prescribed among reproductive age women
5. PRRS Vaccine Market 2018 Forecasts for China: Porcine Reproductive & Respiratory Syndrome is a Major Attraction for Animal Health Enterprises
6. Merck KGaA, Darmstadt, Germany, as Pioneer in Assisted Reproductive Treatments, Takes Leading Role in Fertility Technologies, Announces a Global Collaboration Agreement with Genea Biomedx
7. CCRM Invites Nations Foremost Fertility Experts to Join Its Growing Network of Reproductive Medicine Practices
8. Treato Finds Purple States Drive Reproductive Health Conversations Online
9. Asia Preimplantation Genetic Diagnosis Market to Reach US$28.8 mn by 2023 Supported by Higher Demand for Assisted Reproductive Technology: Transparency Market Research
10. Reproductive Medicine Associates of Texas (RMATX) and INVO Bioscience Announce Positive Patient Results Using the INVO Procedure
11. Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2019)... ... ... and ankle podiatry has been serving the Dexter community for over 15 years. We provide ... help take care of you whether it be ingrown toenails, toenail fungus, https: // ... heel or ankle problems. We can help if you have transplants leg problems. Our podiatrists ...
(Date:1/11/2019)... ... January 11, 2019 , ... Nourished: The Gluten ... Friendly Expo, is returning to the Del Mar Fairgrounds February 9-10 with expanded ... existing Gluten-Free and Nut-Free zones, Paleo, Keto, and Plant-Based zones will provide exciting ...
(Date:1/10/2019)... ... January 10, 2019 , ... Mindray, a leading developer of ... platform, providing a modular, state-of-the-art family of anesthesia solutions. The new series ... unwavering commitment to perioperative care. , “The recently launched Advantage platform further ...
Breaking Medicine Technology:
(Date:1/15/2019)... ... January 15, 2019 , ... Ophthalmic Consultants of Long Island ... to a new, larger space at 70 East Sunrise Highway, Suite 400, Valley Stream, ... of its patients. , According to Gerard D’Aversa, MD, “After serving the Valley Stream ...
(Date:1/14/2019)... ... January 14, 2019 , ... After many months of preparation, ... clinic in Phoenix, Arcadia Allergy & Asthma. This new allergy and asthma clinic is ... a great one stop destination for any immunological and respiratory medical care needs. , ...
(Date:1/14/2019)... ... 14, 2019 , ... Yes, the Millennials love their Bluetooth earbuds and Alexa ... Aging® (ICAA), new tech is also finding a home in senior living communities. , ... from a variety of organizations that work with older adults about their adoption of ...
(Date:1/14/2019)... ... January 15, 2019 , ... Early bird pricing for ... , Risk management is just plain hard, complicated, conflicted, confusing. And it is getting ... the process are not intended as “major”, the new standard adds new definitions, changes ...
(Date:1/14/2019)... ... January 14, 2019 , ... The Centers for ... VARIZIG® (Varicella Zoster Immune Globulin [Human]) for post-exposure prophylaxis of varicella in ... the CDC notes that VARIZIG is commercially available from a broad network of ...
Breaking Medicine News(10 mins):